Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis-Reference-Cited by-同舟云学术

Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis

Published:2011-07-22 Issue:8 Volume:17 Page:905-913
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Saliba Faouzi,Dharancy Sébastien,Lorho Richard,Conti Filoména,Radenne Sylvie,Neau-Cransac Martine,Hurtova Monika,Hardwigsen Jean,Calmus Yvon,Dumortier Jérome

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.22292/fullpdf

Reference49 articles.

1. Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies;Vitko;Am J Transplant,2004

2. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients;Tedesco Silva;Am J Transplant,2010

3. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.;Budde;Lancet,2011

4. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness;Chan;Transplantation,2008

5. Everolimus with very low-exposure cyclosporine A in de novo kidney transplantation: a multicenter, randomized, controlled trial;Salvadori;Transplantation,2009

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions;Expert Review of Clinical Pharmacology;2024-05-16

2. Basics and Art of Immunosuppression in Liver Transplantation;Journal of Clinical and Experimental Hepatology;2024-05

3. Metabolic Disorders in Liver Transplant Recipients: The State of the Art;Journal of Clinical Medicine;2024-02-09

4. Determination of five mTOR inhibitors in human plasma for hepatocellular carcinoma treatment using QuEChERS-UHPLC-MS/MS;Journal of Pharmaceutical and Biomedical Analysis;2023-10

5. Evolving challenges with long‐term care of liver transplant recipients;Clinical Transplantation;2023-08-07